Home » Topics » Regulatory » Patents

Patents
RSS

Breast/prostate cancer treatment agents reported

June 21, 1996

LHRH antagonists disclosed by Takeda

June 21, 1996

Antitumor baccatin derivatives from Tanabe Seiyaku

June 21, 1996

Pierre Fabre reveals cancer treatment agents

June 21, 1996

Bristol-Myers Squibb isolates and synthesizes hayumicin antitumor antibiotics

June 21, 1996

Antibody production-enhancing peptides described

June 21, 1996

Cyclolignan derivatives disclosed

June 21, 1996

Alpha-glucosidase inhibitors from Seikagaku Kogyo

June 21, 1996

Antifungal sordarin derivatives reported by Glaxo Wellcome

June 21, 1996

5alpha-reductase type 1 inhibitors from Merck & Co.

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...